Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study
Cancer Science · 2023
DOI: 10.1111/cas.15943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Mamiko Onuki und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Vaccines, Papillomavirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The first prophylactic vaccine against human papillomavirus (HPV) 16 and HPV18 was licensed in Japan in 2009. HPV vaccine effectiveness against high‐grade cervical lesions has been demonstrated among young Japanese women, but evidence of its effects on invasive cervical cancer (ICC) is lacking. Using data from two different cancer registries, we compared recent trends of new ICC cases by age group using Poisson regression analysis. We also analyzed time trends in HPV16/18 prevalence among 1414 Japanese women aged
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan.
- Division of Medical Engineering, Department of Information Science, Iwate Medical University, Yahaba, Japan.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Japan.
- Department of Obstetrics and Gynecology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
- Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan.
ORCID-Profile: Kazuhiro Takehara, Noriomi Matsumura, Hiroyuki Yamazaki, Keiichiro Nakamura, Junzo Hamanishi, Takuma Fujii, Koji Matsumoto
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Onuki, M., Takahashi, F., Iwata, T., Nakazawa, H., Yahata, H., Kanao, H., Horie, K., Konnai, K., Nio, A., Takehara, K., Kamiura, S., Tsuda, N., Takei, Y., Shigeta, S., Matsumura, N., Yoshida, H., Motohara, T., Yamazaki, H., Nakamura, K., …, & MINT Study Group (2023). Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study. Cancer Science. https://doi.org/10.1111/cas.15943
Vancouver
Onuki M, Takahashi F, Iwata T, Nakazawa H, Yahata H, Kanao H, et al. Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study. Cancer Science. 2023. doi:10.1111/cas.15943
BibTeX
@article{Onuki2023,
author = {Onuki, Mamiko and Takahashi, Fumiaki and Iwata, Takashi and Nakazawa, Hiroshi and Yahata, Hideaki and Kanao, Hiroyuki and Horie, Koji and Konnai, Katsuyuki and Nio, Ai and Takehara, Kazuhiro and Kamiura, Shoji and Tsuda, Naotake and Takei, Yuji and Shigeta, Shogo and Matsumura, Noriomi and Yoshida, Hiroyuki and Motohara, Takeshi and Yamazaki, Hiroyuki and Nakamura, Keiichiro and Hamanishi, Junzo and Tasaka, Nobutaka and Ishikawa, Mitsuya and Hirashima, Yasuyuki and Kudaka, Wataru and Mori-Uchino, Mayuyo and Kukimoto, Iwao and Fujii, Takuma and Watanabe, Yoh and Noda, Kiichiro and Yoshikawa, Hiroyuki and Yaegashi, Nobuo and Matsumoto, Koji and MINT Study Group, MINT Study Group},
title = {Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15943}
}
EUVIMED